LDL-C THERAPEUTIC TARGET ATTAINMENT IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LOMITAPIDE

被引：0

作者：

Underberg, James ^{[1
]}

Harada-Shiba, Mariko ^{[2
]}

Hegele, Robert A. ^{[3
]}

McCullough, Peter A. ^{[4
]}

DiGioia, Kenneth ^{[5
]}

Jurecka, Agnieszka ^{[5
]}

Stefanutti, Claudia ^{[6
]}

Blom, Dirk ^{[7
]}

机构：

[1] NYU, Ctr Prevent Cardiovasc Dis, New York, NY USA

[2] Natl Cerebral & Cardiovasc Ctr, Res Inst, Osaka, Japan

[3] Robarts Res Inst, London, ON, Canada

[4] Baylor Univ, Med Ctr, Dallas, TX USA

[5] Aeger Pharmaceut, Cambridge, MA USA

[6] Sapienza Univ Rome, Rome, Italy

[7] Univ Cape Town, Cape Town, South Africa

来源：

ATHEROSCLEROSIS SUPPLEMENTS | 2018年 / 32卷

关键词：

D O I：

10.1016/j.atherosclerosissup.2018.04.468

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

P5.046

引用

页码：153 / 154

页数：2

共 50 条

[31] FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE
Qureshi, Sarah
ATHEROSCLEROSIS, 2024, 399
[32] LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - FIRST EXPERIENCES IN CLINICAL PRACTICE
Vogt, A.
ATHEROSCLEROSIS, 2016, 252 : E42 - E42
[33] Lomitapide: A Review of its Use in Adults with Homozygous Familial Hypercholesterolemia
Perry, Caroline M.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (04) : 285 - 296
[34] Is lomitapide a life-saving drug in homozygous familial hypercholesterolemia
Bruckert, Eric
Gallo, Antonio
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (17) : 1841 - 1842
[35] PLAQUE BURDEN IN TWO ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: TURNING BACK THE CLOCK WITH AGGRESSIVE LDL-C LOWERING
Nurmohamed, Nick
Reeskamp, Rens
Bom, Michiel
Planken, Nils
Driessen, Roel
van Diemen, Pepijn
Kuipers, Irene
Wiegman, Albert
Hovingh, G. Kees
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 126 - 126
[36] The effect of statin dose on attainment of target LDL-C levels
AI-Zakwani, IS
Bullano, MF
Willey, VJ
Graham, LA
Corbelli, JC
VALUE IN HEALTH, 2003, 6 (03) : 307 - 307
[37] LOMITAPIDE BUT NOT EVOLOCUMAB REDUCES LDL-CHOLESTEROL TO GOAL IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA-2 CASE REPORTS
Vogt, A.
ATHEROSCLEROSIS, 2023, 379 : S122 - S122
[38] Efficacy and Safety of Mipomersen in Patients with Familial Hypercholesterolemia and Inadequately Controlled LDL-C Levels
Ballantyne, Christie
Catapano, Alberico L.
Davidson, Michael
Mittleman, Robert
Moriarty, Patrick M.
Santos, Raul D.
Sensinger, Charlotte
de Banerjee, Samarita
Singleton, Walter
Baker, Brenda F.
Soran, Handrean
Tsimikas, Sotorios
Kastelein, John J.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
[39] EVALUATING THE DISTRIBUTION OF A 12 LDL-C RAISING VARIANTS SCORE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Olmastroni, E.
Gazzotti, M.
Arca, M.
Averna, M.
Casula, M.
Catapano, A. L.
ATHEROSCLEROSIS, 2021, 331 : E177 - E178
[40] FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH UNEXPLAINED LOW LDL-C: A ROLE FOR ANGPTL3?
Reeskamp, L.
Huijgen, R.
Grefhorst, A.
Hovingh, G. K.
ATHEROSCLEROSIS, 2019, 287 : E41 - E41

← 1 2 3 4 5 →